Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
05/14/2014 | CN103070836B 一种环索奈德纳米冻干粉及其制备方法 A cyclic 索奈德纳米 freeze-dried powder and its preparation method |
05/14/2014 | CN103055302B 一种超声生物效应介导的重组人血管内皮抑制素控释制剂 An ultrasound biological effects of recombinant human mediated endostatin controlled release formulation |
05/14/2014 | CN103054863B 一种奥美拉唑钠的药物组合物及其制备方法 One kind of omeprazole sodium pharmaceutical composition and its preparation method |
05/14/2014 | CN103040855B 一种磷酸氟达拉滨的药物组合物及其制备方法 One kind of fludarabine phosphate pharmaceutical composition and its preparation method |
05/14/2014 | CN103006585B 一种注射用埃索美拉唑钠的制备 An injection preparation of esomeprazole sodium with |
05/14/2014 | CN102908338B 白藜芦醇微胶囊的制备方法 Resveratrol microcapsules prepared |
05/14/2014 | CN102895264B 红色诺卡氏菌细胞壁骨架口含片及其制备方法 Nocardia rubra cell wall skeleton buccal tablets and its preparation method |
05/14/2014 | CN102846579B 一种缬沙坦药用胶囊及其制备方法 A pharmaceutical capsule and its preparation method valsartan |
05/14/2014 | CN102824333B 一种口腔速溶膜剂及其制备方法 An oral instant agent and preparation method |
05/14/2014 | CN102791271B 抗凝剂的溶出改善方法 Dissolution method for improving anticoagulant |
05/14/2014 | CN102757626B 一种壳聚糖聚乳酸复合材料的制备方法 Method for preparing polylactic acid composite chitosan |
05/14/2014 | CN102753197B 免疫球蛋白制剂 The immunoglobulin preparation |
05/14/2014 | CN102743329B 一种宫内缓控释给药系统 One kind of controlled release drug delivery system in utero |
05/14/2014 | CN102727524B 一种抗cd3/抗cd133双特异性抗体装载的cik细胞的应用 A cd3 / anti-cd133 bispecific antibody cells loaded with anti-cik |
05/14/2014 | CN102716104B 一种医用有机硅贴片及其制备方法 An organic silicon patch and a preparation method of medical |
05/14/2014 | CN102670685B 凹凸棒艾叶活血化瘀保健膏的生产方法 Attapulgite leaves blood circulation care cream production methods |
05/14/2014 | CN102657873B 一种双亲性聚合物构成的囊泡及其应用 One kind of amphiphilic polymer vesicles and its application |
05/14/2014 | CN102600190B 阿霉素的脂质药物组合物 Doxorubicin liposome pharmaceutical composition |
05/14/2014 | CN102600132B 一种含氨磺必利的口服制剂 One kind of ammonia-containing sulfur will benefit the oral formulation |
05/14/2014 | CN102558546B 聚乙二醇甘草次酸酯、复合载药胶束及其制备方法和用途 Glycyrrhetinic acid esters of polyethylene glycol, complex micelles and their preparation and use |
05/14/2014 | CN102470104B 含有dha酯的非胃肠道给药的药用组合物 Dha esters containing non-parenteral administration a pharmaceutical composition |
05/14/2014 | CN102448449B 粘贴材料 Paste Material |
05/14/2014 | CN102370765B 一种治疗小儿便秘的中药贴剂及其制备方法 A pediatric constipation medicine patch and its preparation method of treatment |
05/14/2014 | CN102362936B 鸡爪芋提取物的用途及其药品和保健品固体制剂、饮料制剂 Chicken and taro extract drugs and health products use solid preparation, beverage preparation |
05/14/2014 | CN102268083B 脱端基纤维蛋白原及其制备方法和应用 Off the end groups of fibrinogen and its preparation method and application |
05/14/2014 | CN102266340B 一种抗结核的凝胶制剂 One kind of anti-TB gel formulation |
05/14/2014 | CN102209558B 使用促性腺激素释放激素(gnrh)组合的变体作为免疫原的药物组合物 Use of gonadotropin-releasing hormone (gnrh) combination variants as immunogens pharmaceutical composition |
05/14/2014 | CN102178643B 一种丁苯酞或其衍生物的微乳透皮凝胶剂及其制备方法 A microemulsion transdermal gel Butylphthalide or derivatives thereof and preparation method |
05/14/2014 | CN102149410B 医疗用复合有机化合物粉体及其制造方法以及悬浮液 The composite organic compound powder for medical use and its manufacturing method, and a suspension of |
05/14/2014 | CN101953794B 一种水飞蓟宾注射剂及制备方法 A flying water injection and preparation method silibinin |
05/14/2014 | CN101909607B 具有尿素成分的透皮治疗系统 Transdermal therapeutic system having the composition of urea |
05/13/2014 | US8722735 Pharmaceutical compositions having desirable bioavailability |
05/13/2014 | US8722706 Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts |
05/13/2014 | US8722700 CCI-779 formulations for parenteral administration |
05/13/2014 | US8722679 Controlled release sterile injectable aripiprazole formulation and method |
05/13/2014 | US8722664 Spontaneously dispersible N-benzoyl staurosporine compositions |
05/13/2014 | US8722115 Methods for improving health in animals |
05/13/2014 | US8722114 Compositions and methods for increasing human growth hormone levels |
05/13/2014 | US8722103 Zeolites for delivery of nitric oxide |
05/13/2014 | US8722092 Nanoparticles made of amorphous cellulose |
05/13/2014 | US8722091 Preparation of submicron sized nanoparticles via dispersion lyophilization |
05/13/2014 | US8722066 Devices and methods for weight control and weight loss |
05/13/2014 | US8722062 Multivalent meningococcal polysaccharide-protein conjugate vaccine |
05/13/2014 | US8722055 Synthetic Streptococcus pneumoniae vaccine |
05/13/2014 | US8722054 Compositions and methods for the treatment or prevention of hepatitis B virus infection |
05/13/2014 | US8722050 Method of treating virus-induced cancer |
05/13/2014 | US8722032 Thiol-selective water-soluble polymer derivatives |
05/13/2014 | US8722030 Composite vaccine adjuvant |
05/13/2014 | US8722012 Method for preventing nasolacrimal duct obstruction |
05/13/2014 | US8721622 Use of a viscoelastic composition for treating increased intraocular pressure |
05/13/2014 | US8720436 Nitric oxide gel apparatus and method |
05/13/2014 | CA2782847C Methods of administering fgf18 |
05/13/2014 | CA2692302C Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
05/13/2014 | CA2676401C Stable pharmaceutical compositions and methods of making and using same |
05/13/2014 | CA2659750C Biogenic silica from silica-containing plant material such as rice hulls |
05/13/2014 | CA2644694C Triggered self-assembly conjugates and nanosystems |
05/13/2014 | CA2637316C A pharmaceutical composition comprising perindopril |
05/13/2014 | CA2623031C Antifungal composition |
05/13/2014 | CA2618966C Bitterness-reducing agent |
05/13/2014 | CA2599018C Methods and systems for operating an aerosol generator |
05/13/2014 | CA2577755C Neublastin variants |
05/13/2014 | CA2386014C Influenza vaccine |
05/13/2014 | CA2270345C Immunostimulatory nucleic acid molecules |
05/09/2014 | CA2795324A1 Pharmaceutical compositions comprising hydromorphone and naloxone |
05/08/2014 | WO2014071387A1 Composition and method for delivery of hydrophobic active agents |
05/08/2014 | WO2014071207A1 Particles for the treatment of inflammatory bowel disease |
05/08/2014 | WO2014071203A1 Sustained release of topical anesthetics |
05/08/2014 | WO2014071190A1 Egcg stabilized gold nanoparticles and method for making same |
05/08/2014 | WO2014071128A1 Macrophage-derived matrix vesicles: an alternative mechanism for microcalcification in atherosclerotic plaques |
05/08/2014 | WO2014070957A1 Antibody/drug conjugates and methods of use |
05/08/2014 | WO2014070659A1 Composition of viral vectors in lecithin liposomes, preparation method and treatment methods |
05/08/2014 | WO2014070622A1 Propynylaminoindan transdermal compositions |
05/08/2014 | WO2014070192A1 Acrylamide derivatives |
05/08/2014 | WO2014069792A1 Pack for supplying carbon dioxide to skin |
05/08/2014 | WO2014069631A1 Vesicle composition, and external preparation for skin and cosmetic preparation each of which contains same |
05/08/2014 | WO2014069615A1 Retinoic acid microneedle |
05/08/2014 | WO2014069401A1 Pulmonary disease-specific therapeutic agent |
05/08/2014 | WO2014068372A1 Pharmaceutical composition of tapentadol for parenteral administration |
05/08/2014 | WO2014068139A1 Novel antigen binding proteins and their use as addressing product for the treatment of cancer |
05/08/2014 | WO2014068029A1 Lyophilized formulation comprising gm-csf neutralizing compound |
05/08/2014 | WO2014068028A1 Topical parasiticidal formulation |
05/08/2014 | WO2014067970A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
05/08/2014 | WO2014067933A1 Bioactive carrier preparation for enhanced safety in care products and food |
05/08/2014 | WO2014048977A9 Albumin binding polypeptide |
05/08/2014 | WO2014043110A3 Crosslinked polymer nano-assemblies and uses thereof |
05/08/2014 | WO2014040591A3 Non-covalent, self-organising hydrogel matrix for biotechnological applications |
05/08/2014 | WO2013186493A3 Composition, in an aqueous medium, including at least one hyaluronic acid and at least one sucrose octasulphate water-soluble salt |
05/08/2014 | WO2006135362A9 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
05/08/2014 | US20140129019 Methods and apparatus for computer-aided tissue engineering for modeling, design and freeform fabrication of tissue scaffolds, constructs, and devices |
05/08/2014 | US20140128797 Compounds for photochemotherapy |
05/08/2014 | US20140128619 Intermediates Useful in the Preparation of Maleimide Functionalized Polymers |
05/08/2014 | US20140128615 Preservation Of Ergothioneine |
05/08/2014 | US20140128588 Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof |
05/08/2014 | US20140128580 Antibody-drug conjugates and methods |
05/08/2014 | US20140128482 Strong reversible hydrogels |
05/08/2014 | US20140128481 Sweet flavor modifier |
05/08/2014 | US20140128479 Absorption Enhancers for Drug Administration |
05/08/2014 | US20140128478 Punctal plug comprising a water-insoluble polymeric matrix |
05/08/2014 | US20140128477 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith |
05/08/2014 | US20140128468 Topical film-forming composition, and use thereof for treating mycoses |